和铂医药控股有限公司（02142）于2026年2月6日披露截至2026年1月31日的股份变动月报表。报告期内，法定股本维持20,000,000,000股，面值USD0.000025，注册总额USD500,000。
截至1月底，公司已发行普通股从上月底的868,681,522股增至869,591,522股，库藏股从25,437,000股增至25,937,000股，总股本达到895,528,522股。报告期内公司因首次公开发售后购股权计划行使新增1,410,000股，同时回购500,000股并转为库存，使当月净增已发行股份910,000股。
首次公开发售后股份奖励计划本月未产生新增发行，累计可发行规模为1,443,000股。公司确认遵守香港联交所相关上市规则及法律法规，公众持股比例符合要求。
公告由执行董事王劲松签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.